These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23208785)

  • 1. Weight changes in Alzheimer's disease patients with increased aberrant motor behavior.
    Secher M; Andrieu S; Gillette-Guyonnet S; Soto M; Rolland Y; Cantet C; Vellas B; Ritz P;
    Int J Geriatr Psychiatry; 2013 Oct; 28(10):998-1004. PubMed ID: 23208785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer's disease subjects.
    White HK; McConnell ES; Bales CW; Kuchibhatla M
    J Am Med Dir Assoc; 2004; 5(2):89-97. PubMed ID: 14984619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.
    Cortes F; Nourhashémi F; Guérin O; Cantet C; Gillette-Guyonnet S; Andrieu S; Ousset PJ; Vellas B;
    Alzheimers Dement; 2008 Jan; 4(1):22-9. PubMed ID: 18631947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia.
    Srikanth S; Nagaraja AV; Ratnavalli E
    J Neurol Sci; 2005 Sep; 236(1-2):43-8. PubMed ID: 15964021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of frontal lobe dysfunction and aberrant motor behaviors in patients with Alzheimer's disease.
    Nagata T; Shinagawa S; Ochiai Y; Kada H; Kasahara H; Nukariya K; Nakayama K
    Int Psychogeriatr; 2010 May; 22(3):463-9. PubMed ID: 20003629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavioral pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD): Spanish validation].
    Boada M; Tárraga L; Modinos G; Diego S; Reisberg B
    Neurologia; 2006; 21(1):19-25. PubMed ID: 16525922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year longitudinal evaluation of neuropsychiatric symptoms in Alzheimer's disease. The REAL.FR Study.
    Benoit M; Robert PH; Staccini P; Brocker P; Guerin O; Lechowski L; Vellas B;
    J Nutr Health Aging; 2005; 9(2):95-9. PubMed ID: 15791352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study.
    Wang PN; Yang CL; Lin KN; Chen WT; Chwang LC; Liu HC
    J Neurol; 2004 Mar; 251(3):314-20. PubMed ID: 15015012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study.
    van Vliet D; de Vugt ME; Aalten P; Bakker C; Pijnenburg YA; Vernooij-Dassen MJ; Koopmans RT; Verhey FR
    Dement Geriatr Cogn Disord; 2012; 34(5-6):319-27. PubMed ID: 23208452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
    Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study.
    Holthoff V; Ferris S; Gauthier S; Ihl R; Robert P; Winblad B; Sternberg K; Tennigkeit F;
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):164-72. PubMed ID: 22492589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuropsychiatric inventory scores change across the mini mental state examination ranges in patients with Alzheimer's disease: a multicenter study in Turkey.
    Yener GG;
    Cogn Behav Neurol; 2009 Dec; 22(4):264-9. PubMed ID: 19996880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale.
    Matsui T; Nakaaki S; Murata Y; Sato J; Shinagawa Y; Tatsumi H; Furukawa TA
    Dement Geriatr Cogn Disord; 2006; 21(3):182-91. PubMed ID: 16401890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease.
    Monsch AU; Giannakopoulos P;
    Curr Med Res Opin; 2004 Jun; 20(6):931-8. PubMed ID: 15200752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation of a brief measure of agitation and aggression in Alzheimer's disease.
    Dennehy EB; Kahle-Wrobleski K; Sarsour K; Milton DR
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):182-9. PubMed ID: 22511516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living alone with Alzheimer's disease: cross-sectional and longitudinal analysis in the REAL.FR Study.
    Nourhashemi F; Amouyal-Barkate K; Gillette-Guyonnet S; Cantet C; Vellas B;
    J Nutr Health Aging; 2005; 9(2):117-20. PubMed ID: 15791356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients.
    Shimabukuro J; Awata S; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):274-9. PubMed ID: 15896220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
    Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R
    Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.